Teva director granted 7,242 RSUs

Zaks Tal Zvi reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Zaks Tal Zvi reported acquisition or exercise transactions in this Form 4 filing.

TEVA PHARMACEUTICAL INDUSTRIES LTD director Tal Zvi Zaks received a grant of 7,242 restricted share units. The grant was made on May 28, 2026 as equity compensation, not as an open-market purchase.

Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. The units vest on May 28, 2027. Following this grant, Zaks holds 7,242 restricted share units directly, each linked to an equal number of underlying ordinary shares, which may be represented by American Depositary Shares on a one-for-one basis.

Insider Trade Summary

Grant/Award: 7,242 shares

Grant/Award 1 txn

Insider Zaks Tal Zvi

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	7,242	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 7,242 contracts (Direct)

Footnotes (3)

1. F1. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
2. F2. Restricted share units were granted on May 28, 2026 and vest on May 28, 2027.
3. F3. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Key Figures

RSUs granted: 7,242 units Post-grant RSU holdings: 7,242 units Exercise/conversion price: $0.0000 per unit +2 more

5 metrics

RSUs granted 7,242 units Restricted share units granted May 28, 2026

Post-grant RSU holdings 7,242 units Total restricted share units held directly after transaction

Exercise/conversion price $0.0000 per unit Restricted share units granted at no exercise price

Vesting date May 28, 2027 Restricted share units vest in full on this date

Underlying ordinary shares 7,242 shares Each restricted share unit linked to one ordinary share

Key Terms

Restricted Share Units, contingent right, Human Resources and Compensation Committee, American Depositary Shares

4 terms

Restricted Share Units financial

"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"represents a contingent right to receive, at settlement, one ordinary share or the cash value"

Human Resources and Compensation Committee financial

"or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share"

A board-level committee that oversees a company’s pay and personnel policies, including executive compensation, employee benefits, hiring, leadership development and succession planning. It matters to investors because the committee shapes incentives, labor costs and management continuity—factors that affect performance, risk and shareholder value—like a coach setting rules and pay that influence how a team performs.

American Depositary Shares financial

"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Tal Zvi Zaks receive in this TEVA Form 4 filing?

Tal Zvi Zaks received a grant of 7,242 restricted share units as equity compensation. Each unit is linked to one ordinary share, or equivalent cash value, subject to vesting conditions and committee discretion.

When do Tal Zvi Zaks’s 7,242 TEVA restricted share units vest?

The 7,242 restricted share units granted to Tal Zvi Zaks vest on May 28, 2027. Vesting means the contingent right converts into ordinary shares or their cash value, according to the plan’s settlement terms.

Does this TEVA Form 4 show an open-market stock purchase or sale?

No, the Form 4 shows a compensation-related grant coded as an acquisition, not an open-market trade. The restricted share units were awarded at no exercise price, reflecting an equity incentive grant rather than a buy or sell decision.

How many TEVA restricted share units does Tal Zvi Zaks hold after this grant?

After this grant, Tal Zvi Zaks holds 7,242 restricted share units directly. Each unit corresponds to one underlying ordinary share, deliverable in shares or cash at settlement under plan and committee terms.

How are TEVA restricted share units settled for Tal Zvi Zaks?

Each restricted share unit entitles Tal Zvi Zaks to receive one ordinary share or the cash value of one share at settlement. The Human Resources and Compensation Committee may choose cash settlement instead of delivering shares.

What is the relationship between TEVA ordinary shares and American Depositary Shares?

The filing states that TEVA ordinary shares may be represented by American Depositary Shares. Each American Depositary Share currently represents one ordinary share, providing a one-for-one correspondence between the two instruments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zaks Tal Zvi

(Last) (First) (Middle)

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 DVORA HANEVI'A ST.,

(Street)

TEL AVIV ISRAEL 6944020

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	05/28/2026		A		7,242		(2)	(2)	Ordinary Shares(3)	7,242	$0	7,242	D

Explanation of Responses:

1. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.

2. Restricted share units were granted on May 28, 2026 and vest on May 28, 2027.

3. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

	/s/ Dov Bergwerk as attorney-in-fact for Tal Zvi Zaks	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)